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Abstract
Adiponectin is an adipose derived hormone that declines in obesity. We have previously shown that exogenous
administration of adiponectin reduces allergic airways responses in mice. T-cadherin (T-cad; Cdh13) is a binding protein for
the high molecular weight isoforms of adiponectin. To determine whether the beneficial effects of adiponectin on allergic
airways responses require T-cad, we sensitized wildtype (WT), T-cadherin deficient (T-cad
2/2) and adiponectin and T-cad
bideficient mice to ovalbumin (OVA) and challenged the mice with aerosolized OVA or PBS. Compared to WT, T-cad
2/2 mice
were protected against OVA-induced airway hyperresponsiveness, increases in BAL inflammatory cells, and induction of IL-
13, IL-17, and eotaxin expression. Histological analysis of the lungs of OVA-challenged T-cad
2/2 versus WT mice indicated
reduced inflammation around the airways, and reduced mucous cell hyperplasia. Combined adiponectin and T-cad
deficiency reversed the effects of T-cad deficiency alone, indicating that the observed effects of T-cad deficiency require
adiponectin. Compared to WT, serum adiponectin was markedly increased in T-cad
2/2 mice, likely because adiponectin that
is normally sequestered by endothelial T-cad remains free in the circulation. In conclusion, T-cad does not mediate the
protective effects of adiponectin. Instead, mice lacking T-cad have reduced allergic airways disease, likely because elevated
serum adiponectin levels act on other adiponectin signaling pathways.
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Introduction
Obesity is a major public health issue [1]. Epidemiological data
indicate that asthma prevalence is increased in obese individuals
[2,3,4,5], and that obesity antedates asthma. Furthermore, weight-
loss improves asthma outcomes [6,7]. The mechanistic basis for
obesity-related asthma remains to be established.
Data from animal models suggest a role for alterations in the
adipocyte-derived hormone, adiponectin, in the relationship
between obesity and asthma. Adiponectin has anti-inflammatory
properties. For example, adiponectin induces an M2, anti-
inflammatory, phenotype in macrophages and inhibits LPS
induced production of TNFa and MCP-1 [8,9,10,11,12,13].
Adiponectin inhibits expression of adhesion molecules such as
VCAM-1 in endothelial cells [14,15] and also induces expression
of the anti-inflammatory genes, IL-10 and the endogenous IL-1
receptor antagonist, IL-1RA [16]. Serum adiponectin declines in
obesity and rises with weight loss, suggesting that loss of the anti-
inflammatory actions of adiponectin in obesity could augment
allergic inflammation. Exogenous administration of adiponectin
inhibits allergic airways responses in mice, including airway
hyperresponsiveness (AHR) and airway eosinophilia [17,18].
Others have shown that adiponectin deficient mice (Adipo
2/2)
exhibit increased responses to chronic allergen challenge [19].
Epidemiological studies also support a beneficial role for
adiponectin in asthma [20].
Three adiponectin binding proteins have been cloned; adipo-
R1, -R2 and T-cadherin (T-cad) [21,22,23]. Lung tissue expresses
all three proteins [21,24,25]. In the heart, the beneficial effects of
adiponectin appear to require T-cad. Adiponectin associates with
heart tissue in wildtype (WT) mice, but not in mice deficient in T-
cad (T-cad
2/2 mice). T-cad
2/2 mice display increased cardiac
hypertrophy following pressure overload and increased infarction
size after ischemia-reperfusion, similar to Adipo
2/2 mice [26].
Importantly, the protective effects of adiponectin in these models
are not observed in T-cad
2/2 mice, suggesting that T-cad
mediates the effects of adiponectin. On the other hand, T-cad
2/
2 mice have substantially elevated serum adiponectin
[26,27,28,29] which would be expected to enhance effects of
adiponectin mediated by other adiponectin binding proteins.
The purpose of this study was to determine the impact of T-cad
deficiency on allergic airways responses. We sensitized and
challenged WT and T-cad
2/2 mice with ovalbumin (OVA) and
measured OVA-induced airway hyperresponsiveness (AHR) and
airway inflammation. To confirm that the observed effects of T-
cad deficiency were the result of the adiponectin binding
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e41088properties of T-cad, we also sensitized and challenged mice
bideficient for adiponectin and T-cad (Adipo
2/2/T-cad
2/2) mice.
Methods
Animals
The following studies were approved by the Harvard Medical
Area Standing Committee on Animals. WT, Adipo
2/2, T-cad
2/
2, and Adipo
2/2/T-cad
2/2 mice were used in this study. T-
cad
2/2 mice were generated as previously described [28].
Adipo
2/2 mice were obtained from Dr. Yuji Matsuzawa [30].
Adipo
2/2/T-cad
2/2 mice were generated by mating Adipo
2/2
mice with T-cad
2/2 mice, backcrossing the offspring with T-
cad
2/2 mice, and mating the resulting Adipo
+/2/T-cad
2/2
offspring. The resulting Adipo
2/2/T-cad
2/2 mice served as
founders for the colony used in this study. Because the Adipo
2/2
mice had been backcrossed to Jackson C57BL/6 mice, whereas
the T-cad
2/2 mice had been backcrossed to Taconic C57BL/6
mice, and because Taconic and Jackson mice differ in their colonic
bacteria [31] which may affect allergic responses, we generated
WT controls for these experiments by mating Jackson and
Taconic C57BL/6 mice, then mating the offspring to Taconic
C57BL/6. The resulting pups became the founders for the WT
mice used as controls for the Adipo
2/2/T-cad
2/2 mice. A similar
process was used to generate the T-cad
2/2 mice that were
compared to the Adipo
2/2/T-cad
2/2 mice. For comparison of
WT and Adipo
2/2 mice, C57BL/6J mice (Jackson Labs, Bar
Harbor, ME) were used.
Protocol
Male WT (C57BL/6 mice), T-cad
2/2 mice, and Adipo
2/2/T-
cad
2/2 mice were sensitized to chicken egg albumin (OVA, grade
V; Sigma-Aldrich Co., St. Louis, MO) on Days 0 and 14 by i.p.
injection of 20 mg of OVA and adjuvant, 2 mg of aluminum
hydroxide (J.T. Baker, Phillipsburg, NJ) dispersed in 0.2 ml of
PBS. On days 28 through 30, mice were challenged for 30 minutes
with either aerosolized PBS or PBS containing 1% OVA (weight/
volume) [32]. Twenty four hours after the last challenge, airway
responsiveness to aerosolized methacholine was assessed, blood
was collected, and bronchoalveolar lavage (BAL) was then
performed. In an additional series of experiments, female WT,
T-cad
2/2, and Adipo
2/2/T-cad
2/2 mice were sensitized in the
same way, but challenged on days 28 through 34 with 6% OVA or
PBS, and examined 48 hours post exposure. For this series, two
cohorts were used, one for airway responsiveness, BAL, tissue
collection and the other for histology. Female WT and Adipo
2/2
mice were also sensitized and challenged with 6% OVA in the
same manner.
Measurement of Pulmonary Mechanics and Airway
Responsiveness
Mice were anesthetized with xylazine (7 mg/kg/i.p) and sodium
pentobarbital (50 mg/kg/i.p), intubated with a tubing adaptor
(18 gauge, Becton Dickinson), and ventilated (FlexiVent,
SCIREQ, Montreal, Canada) with a tidal volume (VT) of 0.3 ml
at 150 breaths/minute. Once ventilation was established, the chest
wall was opened bilaterally to expose the lungs to atmospheric
pressure. A positive end-expiratory pressure (PEEP) of 3 cm H2O
was applied by placing the expiratory line under water. A
standardized volume history was established by twice inflating the
lungs to 30 cm H2O airway opening pressure (total lung capacity,
TLC). In order to measure the static elastic properties of the lung,
we then performed a slow inflation to TLC, followed by a slow
deflation back to end expiratory lung volume. This quasi static
pressure volume (PV) loop was repeated 3 times at 1 minute
intervals for each PV loop, the Salazar Knowles equation [33] was
used to determine the parameters A, B, and K. A is the difference
between TLC and end expiratory lung volume, B is the difference
between TLC and the extrapolated volume at zero transpulmon-
ary pressure, and K is the curvature of the upper portion of the
deflationary limb of the PV curve. Static compliance (Cstat) was
obtained from the lower part of the deflationary limb of the PV
loop. Values from the 3 PV loops were averaged to obtain a mean
value for each animal. Pulmonary mechanics and responses to
inhaled aerosolized methacholine (MCh) dissolved in PBS were
then measured using the forced oscillation technique [34,35] as
follows. First, aerosolized PBS was delivered for 10 seconds using
an ultrasonic nebulizer (Aeroneb, SCIREQ). Pulmonary resistance
(RL) was measured using a sinusoidal forcing function at 2.5 Hz
every 15 seconds for the next three minutes. This sequence was
then repeated with doses of methacholine, increasing from 0.3 to
300 mg/ml. At each dose, the 3 highest values of RL were
averaged.
Bronchoalveolar Lavage
Lungs were lavaged twice with 1 ml PBS and the lavagates
pooled. BAL fluid was centrifuged and total BAL cells and
differentials were assessed as previously described [29]. BAL
supernatant was frozen at 280uC. Total BAL protein was
determined using the Bradford technique (Bio-Rad; Hercules,
CA). BAL adiponectin, IL-13, IL-17, eotaxin, IL-5, MCP-1,
TNFa and MUC5AC were analyzed by ELISA (R&D Systems,
eBioscience, or Biolegend, USA, and Cusabio, Wuhan, China (for
MUC5AC).
Blood Collection
Following euthanasia with pentobarbital sodium, blood was
collected from the heart via right ventricle puncture. Serum was
isolated and stored at 280uC until analyzed for adiponectin and
total IgE, and OVA-specific IgE by ELISA (R&D Systems for
adiponectin, Biolegend, USA for IgE, Cayman, USA for OVA-
specific IgE).
RNA Extraction and Real Time PCR
The lungs were excised and the left lung immersed in RNAlater
(Qiagen) and used to prepare RNA using RNeasy columns
(Qiagen) including a DNase II step to remove genomic DNA. 2 mg
of RNA was converted into cDNA using oligodT and ‘‘First-strand
amplification kit’’ (Invitrogen, USA). T-cad, AdipoR1 and
AdipoR2 mRNA were quantified using real time PCR (7300
Real-Time PCR Systems, Applied Biosystems, US) with primers
previously described [17] and SYBR-green detection. Gene
expression values were normalized to 18S and expressed relative
to WT PBS values, using the delta Ct (DCt) method [36].
Histological Assessment of Pulmonary Inflammation and
Mucous cell Hyperplasia
Lungs were inflated with 10% formalin at 20 cmH2O pressure.
The left lung was embedded in paraffin, sectioned, and stained
with hematoxylin and eosin to determine the inflammation index
(a product of the severity and prevalence of airway inflammation)
using a modification of the method of Hamada et al [37]. Severity
was assigned a numerical value based upon the number of
inflammatory cell infiltrate layers around an airway (0, no cells; 1,
#3 cell layers; 2, 4–9 cell layers; 3, $10 cell layers). Prevalence
was assigned a numerical value according to the percentage of the
circumference encompassed by inflammatory cells (0, none; 1,
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airways was examined and a mean value for each mouse
computed. Other sections were stained with periodic acid-Schiff
(PAS) to identify the prevalence of mucus-containing goblet cells.
For each airway, a mucous hyperplasia index was assigned as
follows: 0, no PAS staining cells; 1, #25%; 2, 25–50%; 3, .50%
of the airway circumference consisted of PAS staining cells.
Dendritic Cell/T-lymphocyte Co-cultures
To determine whether adiponectin impacts dendritic cell
activation of T-lymphocytes, spleens were harvested from DO.11
mice (Jackson Labs, Bar Harbor, ME). These transgenic mice
express the mouse alpha-chain and beta-chain T-cell receptor that
pairs with the CD4 coreceptor and is specific for chicken OVA
323–339 peptide in the context of I-A b. In these mice, T-cells
demonstrate a dose-dependent proliferative response to the
specific OVA ligand. T-cells from DO.11 mice and dendritic
cells from Balb/c mice were isolated from splenocyte suspensions
and co-cultured as previously described [32,38]. To test the
allergen presentation activity of dendritic cells OVA protein
(Sigma) was added to the cultures; control wells were left
unstimulated. Tritiated thymidine (Sigma) was added to assess
lymphocyte proliferation in response to OVA. Cells were washed
48 hours later to remove unincorporated thymidine, lysed, and
radioactivity counted. In some wells, full length or trimeric (C22A)
murine recombinant adiponectin, generated as described below,
was added 24 hours prior to OVA stimulation. Control wells were
treated with the TBS++ buffer used in which adiponectin was
dissolved.
Preparation of Full Length or C22A Adiponectin
cDNA encoding full length murine adiponectin or C22A
adiponectin, each with a 39-Flag tag, was cloned into the
pcDNA3.1(+) mammalian expression vector (Invitrogen, Carls-
bad, CA) as previously described [22] and transfected into HEK
293 cells gifted from Dr C Hug [22] using Lipofectamine 2000
(Invitrogen). Cys22 is required for formation of the hexameric
and hexameric and high molecular weight (HMW) adiponectin
oligomers, and replacing the cysteine at position 22 with an
alanine results in adiponectin that exists as a single trimeric
species, while full length adiponectin generates the trimeric as
well as the HMW isoforms [39]. Transfection medium was
removed after 24 hours, and replaced with serum-free Opti-
MEM I (Invitrogen) supplemented with 100 mg/L ascorbic
acid, 55.5 mg/L CaCl2, and 500 mg/L sodium bicarbonate, pH
7.4. Conditioned medium containing the secreted adiponectin
was collected every 48 hours and replaced with fresh supple-
mented OptiMEM I; a total of 900 mL was collected
representing three collection pools. Collected medium was
centrifuged at 1000 rpm for ten minutes at 4uC to remove
cellular debris and stored at 4uC. For purification using the Flag
tag, pooled conditioned medium was mixed with 4 mL packed
volume M2 Anti-Flag Agarose prepared per manufacturer
(Sigma-Aldrich, St. Louis, MO) overnight at 4uC with gentle
rocking and collected using a column. Unbound protein was
removed by extensive washing (10 bed volumes) with TBS++
(25 mM Tris, 147 mM NaCl, 2.7 mM KCl, 0.9 mM CaCl2,
0.5 mM MgCl2, pH 7.4). Bound adiponectin was eluted in
0.5 mL fractions using three bed volumes of elution buffer
(TBS++) containing 250 ug/mL free Flag peptide. Fractions
containing purified adiponectin were identified by SDS-PAGE
and Coomassie staining, pooled and dialyzed extensively against
TBS++ buffer at 4uC (Pierce Slide-a-Lyzer Casette 10kDa
MWCO). The dialysate was concentrated and analyzed for
purity by silver stain and immunoblot using antibodies against
adiponectin and the Flag epitope (Sigma), and protein
concentration was determined using BCA protein assay kit
(Pierce). Purified protein was stored at 4uC until use.
Statistical Analysis
Comparisons of pulmonary mechanics, BAL, serum, histology,
and mRNA expression were assessed by factorial analysis of
variance (ANOVA), using genotype and challenge as main effects.
Fisher’s least significant difference test was used as a follow-up test.
Statistical analysis was performed using Statistica software
(StatSoft, Inc.; Tulsa, OK). The results are expressed as mean 6
SEM. A p value less than 0.05 was considered significant.
Results
In WT mice, OVA challenge (1% for 3 days) significantly
increased BAL eosinophils, lymphocytes, and neutrophils
(Figure 1A). In T-cad
2/2 mice, this response was significantly
decreased. Consistent with these observations, OVA-induced
increases in BAL IL-13 were significantly reduced in T-cad
2/2
versus WT mice (Figure 1B). These results are opposite in
direction to what would be expected if T-cad was required for
mediating the effects of adiponectin. T-cad is a member of the
cadherin family of cell-cell adhesion molecules, and is implicated
in cell migration, proliferation, adhesion, and survival. Hence, the
observed effects of T-cad deficiency on allergic airways responses
(Figure 1) may be unrelated to its adiponectin binding ability. To
address this possibility, we examined mice deficient in both T-
cadherin and adiponectin (Figure 1). BAL eosinophils and BAL
IL-13 were significantly greater in Adipo
2/2/T-cad
2/2 mice than
in T-cad
2/2 mice, but were not significantly different from WT
mice. Thus, combined T-cad and adiponectin deficiency reversed
the effects of T-cad deficiency alone. The results indicate that
adiponectin is required for the protective effects of T-cad
deficiency in allergic airways inflammation.
Serum adiponectin was almost 3-fold higher in T-cad
2/2 versus
WT mice (Figure 2A) under baseline conditions (PBS challenge).
No changes were observed in response to OVA versus PBS
challenge. BAL adiponectin was significantly greater in OVA
versus PBS challenged mice (Figure 2B), with no notable
differences between genotypes. Note that BAL adiponectin was
substantively lower than serum adiponectin (ng/ml vs mg/ml
respectively) regardless of exposure.
Consistent with the difficulties in inducing AHR by OVA
challenge in C57BL/6 mice reported by others [40] we did not
observe AHR following OVA challenge in WT, T-cad
2/2,o r
Adipo
2/2/T-cad
2/2 mice using this 1% OVA challenge protocol,
whether we used RL, dynamic compliance (Cdyn), airway
resistance, or the coefficients of tissue damping or elastance
(assessed as previously described) [41] as the outcome indicator.
Consequently, we assessed airway responsiveness using a more
intense OVA challenge (6% for 6 days). In WT mice, this latter
OVA challenge protocol did cause AHR (Figure 3A). Moreover,
OVA-induced AHR was abolished in T-cad
2/2 mice, but not in
Adipo
2/2/T-cad
2/2 versus WT mice. Note that airway re-
sponsiveness was similar in WT, T-cad
2/2, and Adipo
2/2/T-
cad
2/2 mice challenged with PBS.
Because unexposed Adipo
2/2 mice have been reported to
develop emphysema as they age [25,29,42,43] which could affect
measurements of airway responsiveness, we also examined
parameters describing the PV curve of the lung (Table 1) of the
PBS challenged mice. Emphysema would be expected to increase
both lung volumes (A and B) and Cstat. However, we observed no
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adiponectin and T-cad on the lung PV curve (Table 1). The mice
were quite young (9 weeks of age) and others have also reported
very limited changes in total lung capacity in Adipo
2/2 mice at
8 weeks of age, whereas TLC is significantly elevated in Adipo
2/2
mice at 30 weeks of age [25].
The impact of T-cad deficiency on BAL inflammatory
parameters was similar using this 6% OVA challenge protocol
as it was with the 1% protocol: OVA challenge caused
significantly greater increases in BAL eosinophils, lymphocytes,
and IL-13 in WT versus T-cad
2/2 mice, and combined
adiponectin and T-cad deficiency reversed the effects of T-cad
deficiency alone (Figures 3B, C). Indeed, BAL lymphocytes,
neutrophils, and IL-13 were actually elevated above WT in
Adipo
2/2/T-cad
2/2 mice. OVA challenge caused a marked
increase in serum total IgE and OVA-specific IgE in mice of all
three genotypes, but there was no effect of genotype on IgE
levels (Figure 3D, E). IL-5 was at or below the limit of detection
of the ELISA in most mice (data not shown). Factorial ANOVA
indicated a significant effect of both OVA exposure and mouse
genotype on BAL eotaxin. Compared to PBS treated mice, BAL
eotaxin was increased in OVA exposed WT and Adipo
2/2/T-
cad
2/2 but not T-cad
2/2 mice (Figure 4A). Given the
importance of eotaxin for eosinophil recruitment in allergic
airways disease [44] the reduction in eotaxin may account for
the decline in BAL eosinophils in the T-cad
2/2 mice
(Figures 1A, 3B). There was also a significant effect of both
OVA challenge and mouse genotype on BAL IL-17 (Figure 4B).
IL-17 was significantly greater in WT than T-cad
2/2 OVA
exposed mice. IL-17 was also greater in Adipo
2/2/T-cad
2/2
versus T-cad
2/2 OVA exposed, although the effect did not
quite reach statistical significance (p,0.07). Given the important
role of IL-17 in neutrophil recruitment [45], IL-17 may account
for some of the genotype related differences in neutrophil
recruitment observed in these mice (Fig. 1A, 3B).
As was the case with the 1% OVA challenge protocol, BAL
adiponectin was significantly greater in mice challenged for 6 days
with 6% OVA than in PBS challenged mice (Figure 2D), but there
was no effect of genotype on BAL adiponectin. Serum adiponectin
Figure 1. Impact of T-cad deficiency on allergic airways responses. We measured BAL cells (A) and IL-13 (B) in wildtype (WT), T-cadherin
deficient (T-cad
2/2), and dual adiponectin and T-cad deficient (Adipo
2/2/T-cad
2/2) mice challenged with 1% ovalbumin (OVA) or PBS. Results
are mean6SEM, n=729. *p,0.05, vs genotype-matched, PBS-challenged mice; #p,0.05, vs OVA- challenged WT. $p,0.05, vs OVA-challenged T-
cad
2/2.
doi:10.1371/journal.pone.0041088.g001
Figure 2. Impact of T-cad deficiency on BAL and serum
adiponectin. Adiponectin levels in serum (A,C) and BAL (B,D) from
1% (A,B) or 6% (C,D) OVA or corresponding PBS-challenged WT and T-
cad
2/2 mice. Mice used in the 1% and 6% OVA experiments were male
and female mice, respectively, which accounts for the greater serum
adiponectin in the mice used in the 6% OVA than the 1% OVA
challenge protocol. Results are mean6SEM. #p,0.05 vs genotype
matched PBS mice; *p,0.05, vs exposure matched WT mice.
doi:10.1371/journal.pone.0041088.g002
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2/2 than the WT mice
(Figure 2C) regardless of challenge.
Because both MCP-1 (CCL2) and TNFa have been shown to
contribute to aspects of allergic airways disease in mice [46,47],
and because expression of both MCP-1 and TNFa is suppressed
by adiponectin in cultured macrophages [9,13], we also measured
BAL MCP-1 and TNFa in these mice (Figures 4C, D). We
observed a different genotype-dependent pattern of changes in
MCP-1 and TNFa, versus the other cytokines and chemokines
examined. OVA-induced increases in MCP-1 and TNFa were not
different in WT and T-cad
2/2 mice, but both cytokines were
increased to a greater extent in Adipo
2/2/T-cad
2/2 than in T-
cad
2/2 mice (Figures 4C, D). Although the data provide evidence
of a role for adiponectin in regulating TNFa and MCP-1
expression in lung during allergic inflammation, they also suggest
that changes in TNFa and MCP-1 do not account for differences
in inflammatory cell recruitment or airway hyperresponsiveness
observed in WT vs T-cad
2/2 mice.
Histology confirmed an increase in inflammatory cells around
the airways after OVA exposure (Figure 5). We did not observe
any significant differences in inflammation in Adipo
2/2/T-cad
2/
2 versus WT mice. However, airway inflammation was signifi-
cantly reduced in T-cad
2/2 mice versus both WT and Adipo
2/
2/T-cad
2/2 mice (Figure 5D). Mucous cell hyperplasia, a key
Figure 3. Effect of dual adiponectin and T-cad deficiency on allergic airways responses. We measured airway responsiveness (A), BAL cells
(B), BAL IL-13 (C), serum total IgE (D) and serum OVA-specific IgE (E) in WT, T-cad
2/2 and Adipo
2/2/T-cad
2/2 mice challenged with 6% OVA or PBS.
Results are mean6SEM, n=629. *p,0.05, vs genotype-matched, PBS-challenged mice; #p,0.05, vs OVA-challenged WT. $p,0.05, vs OVA-
challenged T-cad
2/2.
doi:10.1371/journal.pone.0041088.g003
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mucous hypersecretion index was significantly lower in T-cad
2/2
versus both WT and Adipo
2/2/T-cad
2/2 mice, whereas WT and
Adipo
2/2/T-cad
2/2 were not different. Compared to PBS, OVA
challenge also induced a significant release of MUC5AC in BAL
fluid (Fig. 5F). BAL MUC5AC was greater in Adipo
2/2/T-cad
2/
2 than in either T-cad
2/2 or WT mice. BAL MUC5AC was also
greater in WT versus T-cad
2/2 mice, but the effect did not reach
statistical significance.
For comparison, we also examined allergic airways inflamma-
tion in WT and Adipo
2/2 mice (Figure 6). Compared to PBS,
OVA increased BAL eosinophils and lymphocytes, but there was
no effect of adiponectin deficiency on any BAL cell type
(Figure 6A). Similarly, deficiency in adiponectin alone did not
impact OVA induced increases in BAL eotaxin (Figure 6C), BAL
MUC5AC (Figure 6D), or either serum total IgE or OVA-specific
IgE (Figures 6E, F). BAL adiponectin levels were increased from
baseline (PBS-challenge) in WT mice after OVA-challenge, but
not in serum (Figure 6G, H).
Compared to PBS, OVA challenge decreased the expression
of the adiponectin binding proteins, AdipoR1 and AdipoR2, in
all strains of mice (Figure 7A–D). OVA challenge also decreased
the expression of T-cad in both WT and Adipo
2/2 mice
(Figure 7E) consistent with the hypothesis that changes in levels
of these adiponectin binding proteins contribute to allergic
airways disease.
To determine whether adiponectin might be acting at the level
of dendritic cell presentation of antigens to T cells, we cultured
dendritic cells with T-lymphocytes from DO.11 mice that are
transgenic for a T-cell receptor that recognizes OVA peptide.
Addition of OVA caused a robust increase in lymphocyte
proliferation (Figure 8). However, full length adiponectin (which
contains the trimeric, hexameric and HMW isoforms) [39] had no
Table 1. PV curve parameters of the lungs of female mice
challenged with PBS.
Parameter WT T-cad
2/2
Adipo
2/2/T-cad
2/
2
A (ml) 0.6160.04 0.6760.05 0.6560.05
B (ml) 0.9960.05 1.0760.09 1.0160.09
K (cm H2O
21) 0.14560.004 0.14260.004 0.13260.003
Cstat (ml/cm H2O) 0.07060.004 0.07560.006 0.06960.006
Results are mean 6 SE of data from 6–7 mice in each group. A, B, and K were
derived using the Salazar-Knowles equation [33]; Cstat: static compliance.
doi:10.1371/journal.pone.0041088.t001
Figure 4. Effect of dual adiponectin and T-cad deficiency on cytokine and chemokine expression. BAL eotaxin (A), IL-17 (B), MCP-1 (C),
and TNFa (D) in WT, T-cad
2/2 and Adipo
2/2/T-cad
2/2 mice challenged with 6% OVA or PBS. Results are mean6SEM, n=3 for PBS mice, n=7 for OVA
mice. *p,0.05 vs genotype-matched, PBS-challenged mice; #p,0.05, vs OVA-challenged WT. $p,0.05, vs OVA-challenged T-cad
2/2.
doi:10.1371/journal.pone.0041088.g004
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adiponectin was also without effect (data not shown).
Discussion
T-cad
2/2 mice have markedly elevated blood adiponectin
(Figure 2A, C and [26,28,29]). Results presented in this study
support the hypothesis that this increase in serum adiponectin is
protective against allergic airways responses. Allergic airways
responses were reduced in T-cad
2/2 versus WT mice (Figures 1,
3, 4, 5). Furthermore, dual adiponectin and T-cadherin deficiency
reversed the effects of T-cad deficiency alone (Figures 1, 3, 4, 5)
indicating that the observed effects of T-cad deficiency require
adiponectin.
The purpose of this study was to determine whether T-cad, one
of three adiponectin binding proteins, plays a role in pulmonary
Figure 5. Histological assessment of inflammation and mucous cell hyperplasia. H&E stained sections of PBS-challenged WT (A), 6% OVA-
challenged WT (B) and 6% OVA-challenged T-cad
2/2 mice (C). Inflammation index for airways (D), mucous hyperplasia index (E), and BAL MUC5AC (F).
Results are mean6SEM of 3–5 mice per group in the PBS treated groups and 5–6 mice per group in the OVA treated groups. *p,0.05 vs genotype-
matched PBS-challenged mice; % p,0.05 vs exposure-matched T-cad
2/2 mice; #p,0.05, vs OVA-challenged WT.
doi:10.1371/journal.pone.0041088.g005
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PLoS ONE | www.plosone.org 8 July 2012 | Volume 7 | Issue 7 | e41088responses to allergens. T-cadherin is required for adiponectin to
bind to endothelial cells [28] and cardiomyocytes [26]. Further-
more, the protective effects of adiponectin against cardiac
hypertrophy induced by pressure overload and against cardiac
injury induced by ischemia-reperfusion appear to require T-cad
[26]. Given that T-cad mainly binds the hexameric and HMW
isoforms of adiponectin [22], and that these are the most abundant
isoforms in the lung lining fluid [29], we hypothesized that T-cad
might also be contributing to the ability of exogenously
administered adiponectin to ameliorate allergic airways responses
in mice [17,18]. Consequently, we expected to observe greater
effects of OVA challenge in T-cad
2/2 versus WT mice. Instead,
the opposite occurred: allergen-induced responses were reduced in
T-cad
2/2 versus WT mice (Figures 1,3,4,5).
We considered two potential explanations for this result. First,
T-cadherin has properties in addition to adiponectin binding. It
induces cell de-adhesion and promotes directed cell migration in
vascular cells [49]. In endothelial cells, T-cad stimulates pro-
liferation, migration, and survival under conditions of oxidative
stress and promotes angiogenesis [49,50,51,52]. T-cad also causes
Figure 6. Effect of Adiponectin deficiency on allergic airways responses. BAL cells (A), BAL IL-13 (B), BAL eotaxin (C) BAL MUC5AC (D), serum
total IgE (E) and serum OVA-specific IgE (F) in 6% OVA- or PBS-challenged Adipo
2/2 or WT mice. Serum (G) and BAL (H) adiponectin from the WT mice
are also shown. Results are mean6SEM, n=328 mice/group, *p,0.05 vs genotype-matched, PBS-challenged mice; #,0.05 vs WT, OVA-challenged
mice.
doi:10.1371/journal.pone.0041088.g006
Figure 7. Lung mRNA expression of adiponectin binding proteins, AdipoR1, AdipoR2, and T-cadherin in allergic lungs. mRNA
expression for AdipoR1 and AdipoR2 in 6% OVA- or PBS-challenged WT, T-cad
2/2, and Adipo
2/2/T-cad
2/2 mice (A, B) and WT and Adipo
2/2 mice (C,
D), mRNA expression of T-cadherin in WT and Adipo
2/2 mice (E). Results are mean6SEM, n=628 mice/group. *p,0.05 vs genotype-matched, PBS-
challenged mice.
doi:10.1371/journal.pone.0041088.g007
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cells [24]. These functions, rather than the ability of T-cad to bind
adiponectin, could be responsible for the protective effect of T-
cadherin deficiency. To test this hypothesis we allergen sensitized
and challenged Adipo
2/2/T-cad
2/2 mice and observed that
combined deficiency in adiponectin and T-cad reversed the effects
of T-cad deficiency alone (Figures 1, 3, 4, 5). Thus, the presence of
adiponectin was necessary to elicit the beneficial effects of T-cad
deficiency, indicating that the adiponectin binding properties of T-
cad were likely involved in the responses observed.
The second explanation is that reductions in allergic airway
responses in T-cad
2/2 mice are caused by elevated serum
adiponectin. Serum adiponectin was increased in T-cad
2/2 mice
(Figure 2A, C), consistent with previous observations
[26,27,28,29]. T-cad sequesters adiponectin to the endothelium
and the heart, and thus serves as an adiponectin repository
[26,28]. Consequently, T-cad deficiency delivers this adiponectin
back into the circulation. Thus, the T-cad
2/2 mice resemble mice
given exogenous administration of adiponectin, which are likewise
protected from allergic airways disease [17]. Elevated blood
adiponectin induced by T-cad deficiency may act to inhibit
allergic responses via AdipoR1 and/or AdipoR2, which have been
shown to mediate the insulin sensitizing and anti-apoptotic effects
of adiponectin [53,54]. Alternatively, adiponectin may act in
a non-receptor mediated fashion. For example, adiponectin
interacts directly with growth factors [55] and with other
immunomodulatory factors, including thrombospondin-1 [23]
and calreticulin [56].
Despite substantial increases in serum adiponectin in T-cad
2/2
versus WT mice (Figure 2A, C), BAL adiponectin was not different
(Figure 2B, D). Further, OVA caused a significant increase in BAL
adiponectin in both WT and T-cad
2/2 mice (Figure 2B, D and
Figure 6H), whereas serum adiponectin was not affected
(Figure 2A, C and Figure 6G). It is likely that OVA-induced
increases in BAL adiponectin are the result of increases in lung
alveolar/capillary permeability, since OVA also induced increases
in total BAL protein (data not shown). Marked increases in BAL
adiponectin are also observed in mice exposed to ozone [57],
which also increases lung permeability. The observation that blood
but not BAL adiponectin was affected by T-cadherin deficiency
suggests that extrapulmonary or intravascular targets of adipo-
nectin might contribute to the observed effects of T-cadherin
deficiency. For example, it is conceivable that dendritic cell transit
from the lungs to the lymph nodes, or lymphoid tissue de-
velopment is affected by elevated blood adiponectin in T-cad
2/2
mice. However, such effects would be expected to impact B cell
responses, and OVA-induced increases in IgE were not affected by
T-cadherin deficiency (Figures 3D, E). Bone marrow derived
dendritic cells do have the capacity to respond to adiponectin [58],
and T cells do express adiponectin receptors [59], but our data
(Figure 8) indicate that adiponectin does not affect dendritic cell
presentation of OVA to T-cells, although the background strain of
the mice used for the dendritic cell/T-cell co-cultures was Balb/c
not C57BL/6. Konter et al. recently reported that circulating
adiponectin acting on endothelial cells is important for limiting
lung inflammatory responses to intratracheally administered
endotoxin [27]. Adiponectin has been shown to inhibit TNFa
stimulated ICAM, VCAM, and E-selectin expression on cultured
endothelial cells [14]. Hence, in T-cad
2/2 mice, increased
circulating adiponectin might also be important for limiting
endothelial cell expression of adhesion molecules necessary for
migration of immune and inflammatory cells from the blood into
the lungs. Consistent with this hypothesis, lymphocytes in the
airspaces and BAL concentrations of IL-13 and IL-17, cytokines
typically derived from lymphocytes, were reduced in T-cad
2/2
mice (Figures 1,3,4).
Despite the marked improvement in allergic airways responses
observed when blood adiponectin is elevated by exogenous
administration [17] or when blood adiponectin was elevated
endogenously consequent to T-cad deficiency (Figures 1, 3, 4, 5),
we observed little impact of adiponectin deficiency alone on
allergic airways responses (Figure 6). Under conditions of reduced
adiponectin binding protein expression such as after acute OVA
challenge (Figure 7), normal adiponectin concentrations may be
insufficient to evoke signal transduction, whereas elevated
adiponectin levels in T-cad deficient mice or mice given exogenous
adiponectin may be sufficient to induce signaling. Medoff et al also
reported little impact of adiponectin deficiency on allergic airways
inflammation when they used an acute OVA aerosol challenge
protocol similar to that employed here, although allergic airways
responses were augmented in Adipo
2/2 mice following chronic
intranasal OVA challenge [19]. Those authors suggested that the
milder inflammation induced in the chronic model might make it
easier for effects of endogenous adiponectin to be observed.
Indeed, using the same chronic intranasal OVA challenge as Medoff
et al employed [19], we observed no change in AdipoR1 or
AdipoR2 following OVA challenge (unpublished observations),
suggesting that this milder inflammation should allow normal
endogenous adiponectin concentrations to evoke effective signal
transduction. In any event, our data suggest that effects of
adiponectin can be uncovered in the acute OVA model by
elevating the blood adiponectin levels via T-cad deficiency: T-
cad
2/2 mice lacking adiponectin had increased responses to OVA
compared to T-cad
2/2 mice that did have adiponectin (Figures 1,
3, 4, 5). Reports from several large genome wide association
studies indicate that variation in serum adiponectin concentrations
among humans is in part explained by SNPs in the promoter of
the T-cad gene [60,61]. Our data suggest that the T-cad genotype
Figure 8. Effect of full length adiponectin on T-cell pro-
liferation induced by culture with OVA stimulated dendritic
cells. T-cells isolated from spleens of OVA-TCR transgenic mice were
incubated with dendritic cells from WT mice and stimulated with OVA.
Tritiated thymidine was added to assess cell proliferation. ‘‘0’’
adiponectin wells were treated with the vehicle (TBS++) used to
dissolve adiponectin. CPM=counts per minute. Results are mean 6
SEM of data from 6 wells in each condition. Data are expressed as a % of
the OVA treated wells that received only vehicle.
doi:10.1371/journal.pone.0041088.g008
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adiponectin for human asthma.
In conclusion, T-cad does not mediate the protective effects of
adiponectin. Instead, mice lacking T-cadherin have reduced
allergic airways disease. This reduction is dependent on adipo-
nectin, and likely occurs consequent to elevated serum levels of
adiponectin acting on other adiponectin signaling pathways such
as AdipoR1 or AdipoR2.
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